Literature DB >> 4153372

High-dose penicillin therapy and pneumococcal pneumonia.

A Brewin, L Arango, W K Hadley, J F Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4153372

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

Review 2.  Infectious diseases: fortieth and final annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

3.  Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia.

Authors:  A Ortqvist; S Hammers-Berggren; M Kalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

Review 4.  Common bacterial infections in infancy and childhood. 1. Respiratory infections.

Authors:  H C Spratt; G A Ahronheim; M I Marks
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

5.  Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver.

Authors:  G R Istre; J T Humphreys; K D Albrecht; C Thornsberry; J M Swenson; R S Hopkins
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

Review 6.  Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations.

Authors:  M LeBel; M Spino
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

7.  Serotypes and penicillin susceptibility of pneumococci isolated from blood.

Authors:  B A Lauer; L B Reller
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

8.  Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; A L van Gerwen; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 9.  Gastro-oesophageal reflux disease.

Authors:  Ronnie Fass; Guy E Boeckxstaens; Hashem El-Serag; Rachel Rosen; Daniel Sifrim; Michael F Vaezi
Journal:  Nat Rev Dis Primers       Date:  2021-07-29       Impact factor: 52.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.